Clinical Report: Links Between Maternal Thyroid Hormone Levels and Neonatal Outcomes
Overview
This study investigates the dynamics of maternal thyroid hormones across pregnancy trimesters and their associations with neonatal outcomes. Findings indicate trimester-specific changes in thyroid hormone levels and weak correlations with neonatal birth weight, length, and parity.
Background
Maternal thyroid hormones play a crucial role in fetal development and metabolic regulation during pregnancy. Understanding their dynamics and impact on neonatal outcomes is essential for optimizing maternal and infant health strategies. Despite existing literature, comprehensive studies examining these relationships across all trimesters are limited.
Data Highlights
No specific numerical data provided in the source material.
Key Findings
Maternal TSH levels increase gradually throughout pregnancy.
TT3 levels peak in mid-pregnancy, while FT3 and FT4 levels decline continuously.
Weak correlations exist between maternal thyroid hormones and neonatal outcomes.
Trimester- and sex-specific associations of TT4, TT3, FT3, and FT4 with birth weight, length, and parity were observed.
RCS analysis revealed dose-response relationships with pregnancy stage and sex-specific patterns.
BKMR indicated weak positive correlations of thyroid hormone mixtures with neonatal outcomes in early/mid-pregnancy and significant positive correlations in late pregnancy.
Clinical Implications
Monitoring maternal thyroid function throughout pregnancy is important for assessing potential impacts on neonatal health. Clinicians should consider trimester-specific reference ranges when evaluating thyroid hormone levels in pregnant patients.
Conclusion
The study highlights the importance of understanding maternal thyroid hormone dynamics and their associations with neonatal outcomes, emphasizing the need for ongoing monitoring during pregnancy.
